Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 19, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - September 19, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/20/17 - Drug-price ballot failure in California could mean bad prognosis in Ohio [The Blade, Toledo, Ohio]
Aug. 20 COLUMBUS Even as California voters last fall were rejecting a proposed law to limit what taxpayers pay for prescription drugs, the measure's backers already had secured their second bite at the apple in Ohio. "In California, you can't assume a liberal measure is always going to pass," said Jack Pitney, professor of government at Clar
8/20/17 - KEVIN BRYANT: Culture change needed to fight opioid crisis
The opportunity to serve the Anderson community as an independent neighborhood pharmacist humbles me daily. Our access to a wide variety of medicines is the envy of most of the world, and it helps us lead happy and productive lives. But some of our loved ones succumb to a disease triggered by the very medicines that should help them.
8/20/17 - Landmark trial is using PET scans to diagnose Alzheimer's disease
By a News Reporter-Staff News Editor at VerticalNews Health& Science MAYWOOD, IL- Loyola Medicine is participating in a landmark $100 million study of the effectiveness of using PET scans to detect Alzheimer's disease. Alzheimer's disease has been linked to clumps of amyloid proteins, which block signals in the brain. The tracer drug has been app
8/20/17 - Mylan finalizes settlement over Medicaid payments for EpiPen
PITTSBURGH Generic drug giant Mylan announced Thursday it has finalized its settlement with the U.S. Department of Justice for overcharging Medicaid for the EpiPen. The settlement amount is $465 million, unchanged from when Mylan announced a preliminary deal in October that was criticized by lawmakers and others as not being harsh enough.
8/20/17 - Scientists create stem cell therapy for lung fibrosis conditions
By a News Reporter-Staff News Editor at VerticalNews Health& Science CHAPEL HILL, NC- A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis, chronic obstructive pulmonary dis
8/19/17 - "Improved Factor Viii Preparations Suitable for Therapeutic Use and Processes to Obtain These" in Patent Application Approval Process (USPTO...
"Improved Factor Viii Preparations Suitable for Therapeutic Use and Processes to Obtain These" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors SCHMIDBAUER, Stefan; METZNER, Hubert; ROBBEL, Lars, filed on July 24, 2015, was made available online o
8/19/17 - Attorney General Mills Announces Settlement With Maker of EpiPen for Overbilling Taxpayers
Maine Attorney General Janet T. Mills issued the following news release:. Attorney General Janet T. Mills announced today that Maine has agreed in principle to join the United States and other States to settle allegations against Mylan Inc. and its wholly-owned subsidiary, Mylan Specialty L.P.. Mylan Specialty is a Delaware limited partnership with
8/19/17 - Attorney General Shapiro Announces Mylan Pharmaceuticals to Pay Pennsylvania $8.3 Million in Restitution Over EpiPen Scam
Pennsylvania Attorney General Josh Shapiro issued the following news release:. Attorney General Josh Shapiro announced that Pennsylvania, along with the U.S. Justice Department, has finalized a settlement with the drug manufacturer Mylan Inc., resolving claims that it overcharged taxpayers for its EpiPen emergency allergy treatment.
8/19/17 - Blood and Organ Bank Market Research Report by Geographical Analysis and Forecast to 2023
Transparency Market Research Report Added "Blood and Organ Bank Market" to its database.Albany, NY 08/18/2017 Blood transfusion and Organ transplant is done to save the life of an individual or to improve patient's health. According to the World Health Organization, out of 108 million blood donations done globally, 50% of the blood donations
8/19/17 - Citius Pharmaceuticals, Inc. Prices $6,800,000 Public Offering And Listing On The Nasdaq Capital Market
By a News Reporter-Staff News Editor at Investment Weekly News CITIUS PHARMACEUTICALS, INC., a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced the pricing of an underwritten public offering of 1,648,484 shares of its common stock and warrants to purchase up to an aggregate of 1,648,484
8/19/17 - Delaware Medicaid Program to Be Reimbursed Almost $900K for Overcharges on EpiPens
Delaware Attorney General Matthew Denn issued the following news release:. The Medicaid Fraud Control Unit of the Delaware Department of Justice will join the United States and other states to settle allegations against Mylan Inc. and its wholly-owned subsidiary, Mylan Specialty L.P.. Mylan Specialty owns the exclusive rights to sell EpiPen in the
8/19/17 - Emergency Veterinary Services Market 2024 Overview, Competitive Analysis and Development by Companies
Albany, NY 08/18/2017 Emergency Veterinary Services Market: Overview Veterinary medicine is a branch of science that is related with treatment, diagnostic, prevention of disease, illness, injury or disorders in animals. The scope of veterinary medicines is vast and covers wide range of diseased conditions that can affect different animal spec
8/19/17 - FDA grants two orphan drug designations for HCC [Sudan Tribune]
The U.S. Food and Drugs Administration has granted two orphan drug designations for T cell therapy products for the treatment of hepatocellular carcinoma. The FDA Orphan drug designations are granted to drugs and biologics intended for rare diseases that affect fewer than 200,000 people in the U.S, and provides incentives that may include tax credi
8/19/17 - FDA May Limit `Risk Info` in Direct-to-Consumer TV Drug Ads [Times of Oman]
But a new approach being considered could trim those lists to feature only the most serious and potentially fatal side effects, the FDA said Friday. To come to the best solution, the FDA is asking consumers, doctors and others to comment on which risk information is most helpful in TV and other broadcast ads. Nachum Katlowitz, director of urology a
8/19/17 - ICYMI: Chairman Walden on #FDARA Becoming Law
Greg Walden, R- Ore., chairman of the House Energy and Commerce Committee, issued the following news:. Today, President Trump signed H.R. 2430, the FDA Reauthorization Act of 2017, into law. Highlighting these vital elements, Energy and Commerce Committee Chairman Greg Walden made his first post on the committee's new Medium account to explain why
8/19/17 - JUNO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Juno Therapeutics, Inc. - JUNO
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick& Foti, LLC, announces that KSF has commenced an investigation into Juno Therapeutics, Inc.. In November 2016, it was revealed that the FDA had suspended the JCAR015 trial and on March 1, 2017, the Company announced it was ending the drug tria
8/19/17 - Madigan Reaches $4.5 Milion Settlement With Drugmaker Insys for Deceptively Selling, Marketing Highly Addictive Opioid Painkiller
Illinois Attorney General Lisa Madigan issued the following news release:. Attorney General Lisa Madigan today announced a $4.45 million settlement with the pharmaceutical company Insys Therapeutics Inc. for deceptively marketing and selling a highly addictive opioid drug for an array of treatments that were not approved by the Food And Drug...
8/19/17 - Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability
The Acting U.S. Attorney for the District of Massachusetts, William D. Weinreb, issued the following news release:. The U.S. Attorney's Office announced today that pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve allegations that they violated the False Claims Act by knowingly misclassifying Ep
8/19/17 - Mylan, DOJ: Deal reached in EpiPen case [The Dominion Post, Morgantown, W.Va.]
Aug. 19 The Department of Justice and Mylan NV announced a $465 million settlement Friday related to the pharma-ceutical company mislabeling EpiPens and avoiding paying money to rebate programs, including Medicaid. Acting Assistant Attorney General Chad A. Readler, of the DOJ? Acting U.S Attorney William D. Weinreb said. ?
8/19/17 - New Reproductive Medicine Findings Reported from T. D'Hooghe and Co-Authors (Transparent collaboration between industry and academia can serve unmet...
By a News Reporter-Staff News Editor at Marketing Weekly News Research findings on Women's Health- Reproductive Medicine are discussed in a new report. In Europe, the transparency of this collaboration between pharmaceutical industry and medical doctors has been made possible by the Compliance and Disclosure Policy published by the European Feder
8/19/17 - New treatment for deadly blood cancers expected to be approved soon [St. Louis Post-Dispatch]
Aug. 19 Cancer doctors in St. Louis are ready to use a new therapy using a patient's own blood to fight their disease. At least 16 of the 20 people who have received CAR-T therapy for leukemia or lymphoma through clinical trials at Washington University's Siteman Cancer Center have seen their cancers disappear after treatment. Armin Ghobadi, an a
8/19/17 - Opioid drugmaker settles with Illinois for $4.5 million [Chicago Tribune]
Aug. 18 An Arizona drug company has agreed to pay Illinois $4.45 million to settle allegations that it deceptively marketed and sold a prescription opioid drug for uses not approved by the U.S. Food and Drug Administration. Illinois sued the company in August of last year in Cook County Circuit Court, alleging Insys deceptively marketed and sold
8/19/17 - Pfizer wins approval for blood cancer drug Besponsa [Sudan Tribune]
Pfizer today won FDA approval for a new targeted drug for the treatment of relapsed or refractory acute lymphoblastic leukemia. The FDA said nearly 6,000 people in the U.S. will be diagnosed with ALL this year and about 1,440 will die from the disease. A Pfizer spokesperson said in an email, that based on the typical duration of treatment, the tota
8/19/17 - PLx Opco, Houston, Assigned Patent for pH Dependent Carriers for Targeted Release of Pharmaceuticals
PLx Opco, Houston, has been assigned a patent developed by four co-inventors for "pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same." The co-inventors are Upendra K. Marathi, Houston, Susann Edler Childress, Houston, Shaun L. Gammill, Houston, and Robert
8/19/17 - President Trump Signs OTC Hearing Aid Legislation into Law
On Friday, August 18, President Donald Trump signed into law today the Food and Drug Administration Reauthorization Act of 2017, legislation that includes the Over the Counter Hearing Aid Act designed to provide greater public accessibility and affordability with over-the-counter (OTC) hearing aids. FDA will now be charged with creating and regula
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement